Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Home video workouts may cut hospital stays for lung disease patients

NCT ID NCT05119556

Disease control Sponsor: University of Alabama at Birmingham Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a 13-week home exercise program, done via live video calls, can reduce hospital readmissions in people with COPD. 301 patients who were recently hospitalized for a COPD flare-up will either get the video rehab or standard care. The goal is to see if this approach improves breathing, quality of life, and saves money.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
video telehealth pulmonary rehabilitation (exercise sessions via videoconferencing)
What this could lead to
If successful, this could offer a convenient home-based program to help COPD patients avoid repeat hospital stays and improve their quality of life.
What could go wrong
This is a single study with 301 participants, and the intervention is behavioral, so results may vary. It may not work for everyone, and home exercise carries a small risk of injury or falls.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

301 people

The number who actually took part.

Started

Jun 2022

Expected to finish

Feb 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age 40 or greater 2. Clinical diagnosis of COPD 3. Hospitalized for acute exacerbation of COPD. 4. Be willing to adhere to trial and follow-up procedures and give informed consent Exclusion Criteria: 1. Secondary diagnosis of congestive heart failure that is severe as documented by active symptoms, New York Heart Association (NYHA) functional classification IV or left ventricular ejection fraction \<25% on echocardiography 2. Other respiratory conditions that could confound the diagnosis such as asthma, pulmonary fibrosis, bronchiectasis, and lung cancer. Participants with pneumonic exacerbations of COPD will be included. 3. Primary diagnosis of COVID pneumonia. Individuals with incidentally detected COVID or persistently positive for COVID but deemed to be convalescent will not be excluded. 4. Active cancers on chemotherapy or radiation therapy 5. Immunosuppressed states predisposing to frequent hospitalizations including uncontrolled HIV/AIDS 6. Active or recent (within 1 month) myocardial infarction 7. Angina not well-controlled by medication 8. Unstable cardiac arrhythmias, atrial or ventricular 9. Supplemental oxygen requirement greater than 5 liters per minute at either rest or with exertion 10. Significant cognitive dysfunction, including dementia, that in opinion of investigator would impair ability to safely or effectively engage in study protocol 11. Participants with any terminal medical illnesses as diagnosed by a physician, and/or on hospice 12. Currently enrolled in and participating in pulmonary rehabilitation 13. Treatment with chronic or newly initiated home ventilatory support. Those on in-patient short-term non-invasive ventilation will not be excluded. 14. Special patient groups such as prisoners and institutionalized patients 15. Participants with musculoskeletal comorbidities or physical infirmities that preclude participation in an exercise program 16. Current participation in any other interventional clinical trial 17. Inability to understand and speak English during exercise sessions 18. Inability or unwillingness to comply with study and/or follow-up procedures outlined in the protocol

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic obstructive pulmonary disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic obstructive pulmonary disease

Contacts and locations

Locations

  • Baylor College of Medicine

    Houston, Texas, 77030, United States

  • Boston VA Hospital

    Boston, Massachusetts, 02130, United States

  • Cincinnati VA Hospital

    Cincinnati, Ohio, 45220, United States

  • Cleveland Clinic

    Cleveland, Ohio, 44195, United States

  • HealthPartners Institute

    Bloomington, Minnesota, 55440, United States

  • Johns Hopkins University

    Baltimore, Maryland, 21287, United States

  • Minnesota VA HealthCare System

    Minneapolis, Minnesota, 55455, United States

  • Northern Westchester Hospital/Northwell Health

    Chappaqua, New York, 10514, United States

  • Northwestern Memorial Hospital

    Chicago, Illinois, 60611, United States

  • Temple University Hospital

    Philadelphia, Pennsylvania, 19122, United States

  • University of Alabama at Birmingham

    Birmingham, Alabama, 35233, United States

  • University of Iowa

    Iowa City, Iowa, 52242, United States

  • University of Maryland

    College Park, Maryland, 20742, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, 15260, United States

  • Wake Forest University

    Winston-Salem, North Carolina, 27109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.